Dr. Donald Gregory Farwell, MD

Dr. Farwell practices at Good Shepherd Penn Partners - HOPD (3400 Spruce Street, White Bldg 1st Flr) in Philadelphia, Pennsylvania.

Dr. Farwell's NPI, 1972587525, was assigned on December 6, 2005. Dr. Farwell graduated from WashU Medicine in 1994. Dr. Farwell holds Pennsylvania license MD474521.

Dr. Farwell's primary practice is Good Shepherd Penn Partners - HOPD (3400 Spruce Street, White Bldg 1st Flr), at 3400 Spruce Street, White Bldg 1st Flr, Philadelphia, PA 19104.

Dr. Farwell's primary practice is Good Shepherd Penn Partners - HOPD (3400 Spruce Street, White Bldg 1st Flr) in Philadelphia, Pennsylvania. Dr. Farwell is also affiliated with Hospital of the University of Pennsylvania. The medical group on file is Penn Medicine Lancaster General Health. Dmand AI also links Dr. Farwell to 1 more hospital, named with a free account. Dr. Farwell's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Farwell practices, 3 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Farwell's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Farwell is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Farwell's licenses on file in 3 states: Pennsylvania, California and Washington.

Dmand AI lists larynx and vocal cord disease and thyroid surgery among the conditions Dr. Farwell treats.

CMS data shows 234 Medicare services from Dr. Farwell across 5 procedure codes in 2024, for 98 Medicare patients. Medicare paid $14,730 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 98 Medicare patients who saw Dr. Farwell in 2024. The largest group is 65 to 74, with 49 patients. 75% of them have high cholesterol, and 69% have high blood pressure. Their average risk score is 1.35, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Farwell's median patient age at 69, with 48% women.

In 2019, Dr. Farwell wrote 12 Medicare Part D claims. They cover 1 drug, with $98 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Farwell for performance year 2024, reported as part of a group. Dr. Farwell accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 109 papers to Dr. Farwell, published from 2007 to 2024. 2019 was the busiest year, with 10. The most frequent topics are Head and Neck Neoplasms, Carcinoma, Squamous Cell and Mouth Neoplasms. Dr. Farwell has published most often in Head Neck. Dr. Farwell's most frequent co-authors are Allen M. Chen, MD, Arnaud F. Bewley, MD and Quang Cat Luu, MD.

CMS Open Payments shows 36 general payments to Dr. Farwell from 4 drug and device companies from 2016 to 2025. Accredited education speaker fees make up the largest share, 38% of the total. Synthes GmbH paid the most, $18,553.

Dmand AI lists 2 awards for Dr. Farwell, most recently CMS Stage 1 EHR in 2012.

Dr. Farwell graduated from WashU Medicine in 1994. Dr. Farwell is a member of ACS.

Dr. Farwell is in network with 19 carriers, including Aetna, Blue Cross Blue Shield of Michigan and HCSC. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.